order to profit off of its highly-priced HIV treatment drugs. Closing arguments in a six-week trial wrapped Wednesday, leaving a federal jury to consider weeks of evidence regarding the pharmaceutical
versions of the HIV prevention drug Lenacapavir in 120 low- and middle-income countries. Among these countries is India which has the biggest generic drug industry outside the U.S. Lenacapavir has been
Jan 15 (Reuters) - Gilead Sciences (GILD.O) and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to a Wednesday
total 1 pages, 3 items